Eating disorders and disordered eating on wrestling sport: a systematic review
Abstract
Although there are studies on the effects of eating disorders (EDs) among athletes, a limited number of studies have been conducted in wrestling. This systematic review aims to identify the prevalence of eating disorders (ED) and disordered eating (DE) in wrestling, which is important for developing healthier weight control behaviours within the sport. A systematic review was conducted following the PRISMA protocol, focusing on publications from the last 10 years. PubMed, Scopus, PsycINFO, SPORTDiscus and Web of Science were used to identify eligible studies with the searching terms “Eating disorders” AND “wrestlers” OR “Eating disorders” AND “wrestling” OR “Disordered eating” AND “wrestlers” OR “Disordered eating” AND “wrestling” OR “Anorexia Nervosa” AND “wrestlers” OR “Anorexia Nervosa” AND “wrestling” OR “Bulimia Nervosa” AND “wrestlers” OR “Bulimia Nervosa” AND “wrestling” within the timeframe from 2014 to 2024. Eight articles met the inclusion criteria. When all studies were considered as a homogeneous group, the analysis revealed: (a) wrestlers are significantly more susceptible to Eds than other branches, (b) wrestlers have unhealthy weight control behaviors to control weight for optimum performance and to enhance their muscular appearance due to body image issues. It is recommended that future research address eating disorders, which have predominantly been studied in male wrestlers, within female wrestlers as well. Additionally, it is advised to identify potential…
How strong is the evidence?
Evidence Hub reads this as a systematic review. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.